MoneyWorks4Me

Mercury Laboratories informs about disclosure

21 Jun 2024 Evaluate

Pursuant to Regulation 30 and Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Regulations’), Mercury Laboratories has informed that it enclosed the sample letter dispatched to the concerned shareholders of the Company who have not claimed their final dividend for year 2016-17.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1841.50
Dr. Reddys Labs. 1243.65
Cipla 1386.75
Lupin 2083.15
Zydus Lifesciences 1213.55
View more..